Dottorato in Medicina Molecolare

 

1. STAT3 can serve as a hit in the process of malignant transformation of primary cells. M Demaria, S Misale, C Giorgi, V Miano, A Camporeale, J Campisi, P Pinton, V Poli. Cell Death and Differentiation 2012.

 

2. Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer. Sandra Misale, Rona Yaeger, Sebastijan Hobor, Elisa Scala, Manickam Janakiraman, David Liska, Emanuele Valtorta, Roberta Schiavo, Michela Buscarino, Giulia Siravegna,  Katia Bencardino, Andrea Cercek, Chin-Tung Chen, Silvio Veronese, Carlo Zanon, Andrea Sartore-Bianchi, Marcello Gambacorta, Margherita Gallicchio, Efsevia Vakiani, Valentina Boscaro, Enzo Medico, Martin Weiser, Salvatore Siena, Federica Di Nicolantonio, David Solit and Alberto Bardelli. Nature 2012

 

3. KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy.

Valtorta E, Misale S*, Sartore-Bianchi A, Nagtegaal ID, Paraf F, Lauricella C, Dimartino V, Hobor S, Jacobs B, Ercolani C, Lamba S, Scala E, Veronese S, Laurent-Puig P, Siena S, Tejpar S, Mottolese M, Punt CJ, Gambacorta M, Bardelli A, Di Nicolantonio F. Int J Cancer. 2013

*Co-First Author

53rd Meeting of the Italian Cancer Society, 19th-22nd October 2011 Turin, Italy;

IRCC International Conference Molecular Clinical Oncology 26th-28th May 2011, Turin, Italy;

AACR Annual Meeting 2012, March 31st -April 4th 2012, Chicaco,IL ;

WIN Symposium in Personalized Carcer Medicine, June 28-29 2012, Paris, France